Factor XI deficiency and aortic valve replacement: Perioperative management.

Abstract

Severe factor XI deficiency (hemophilia C) is a rare coagulation disorder. A 73-year-old woman, a homozygote for factor XI deficiency, required aortic valve replacement. An initial dose of 15 U kg-1 of factor XI concentrate was administered preoperatively and on postoperative day 3. During surgery, concentrated red cells, fresh frozen plasma, platelets… (More)
DOI: 10.1177/0218492316644075

Topics

Cite this paper

@article{Petroulaki2017FactorXD, title={Factor XI deficiency and aortic valve replacement: Perioperative management.}, author={Aristea Petroulaki and George L Lazopoulos and Fotini Chaniotaki and Emmanuel Kampitakis and Dionysis Pavlopoulos and George E. Chalkiadakis}, journal={Asian cardiovascular & thoracic annals}, year={2017}, volume={25 6}, pages={450-452} }